Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Original Article

S. Modi, W. Jacot, T. Yamashita, J. Sohn, M. Vidal, E. Tokunaga, J. Tsurutani, N.T. Ueno, A. Prat, Y.S. Chae, K.S. Lee, N. Niikura, Y.H. Park, B. Xu, X. Wang, M. Gil-Gil, W. Li, J.-Y. Pierga, S.-A. Im, H.C. Moore, H.S. Rugo, R. Yerushalmi, F. Zagouri, A. Gombos, S.-B. Kim, Q. Liu, T. Luo, C. Saura, P. Schmid, T. Sun, D. Gambhire, L. Yung, Y. Wang, J. Singh, P. Vitazka, G. Meinhardt, N. Harbeck, and D.A. Cameron

N Engl J Med 2022;387:9-20

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
07/06/2022
Course expires: 
07/07/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation